Subjects: H.R.5311 — 107th Congress (2001-2002)

  • Access to health care
  • Actions and defenses
  • Administrative procedure
  • Commerce
  • Competition
  • Confidential communications
  • Congress
  • Congressional reporting requirements
  • Damages
  • Department of Health and Human Services
  • Drug approvals
  • Drug industry
  • Drugs
  • Generic drugs
  • Government Operations and Politics
  • Government paperwork
  • Government publicity
  • Health
  • Injunctions
  • Intellectual property
  • Law
  • Limitation of actions
  • Marketing
  • Patent infringement
  • Patents
  • Prescription pricing
  • Restrictive trade practices
  • Trade secrets